WolverHeme Happy Hour cover image

Episode 32: Navigating a BlinatumoMAD World

WolverHeme Happy Hour

00:00

High-Risk Strategies and Inotuzumab Considerations

Julia and Bernie discuss 1732 and inotuzumab toxicity concerns, and the rationale for using blinatumomab in some high‑risk patients.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app